Incidence and Severity of Drug Interactions Before and After Switching Antiretroviral Therapy to Bictegravir/Emtricitabine/Tenofovir Alafenamide in Treatment-Experienced Patients

BACKGROUND: Switching antiretroviral therapy (ART) in people with HIV (PWH) can influence their risk for drug–drug interactions (DDIs). The purpose of this study was to assess changes in the incidence and severity of DDIs among PWH who switched their ART to bictegravir/emtricitabine/tenofovir alafen...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Open Forum Infect Dis
Main Authors: Schafer, Jason J, Pandit, Neha S, Cha, Agnes, Huesgen, Emily, Badowski, Melissa, Sherman, Elizabeth M, Cocohoba, Jennifer, Shimada, Ayako, Keith, Scott W
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2020
Assuntos:
Major Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7813207/
https://ncbi.nlm.nih.gov/pubmed/33511239
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofaa625
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados